Aimed Bio Inc. (KOSDAQ:0009K0)
South Korea flag South Korea · Delayed Price · Currency is KRW
33,750
-450 (-1.32%)
At close: Jun 2, 2026

Aimed Bio Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22
Net Income
4,0745,023-3,304-9,023-6,168
Depreciation & Amortization
1,4811,3821,4641,058780.45
Loss (Gain) From Sale of Assets
16.2216.22-0.667.2412.95
Loss (Gain) From Sale of Investments
1,254317.63-96.751,084716.25
Stock-Based Compensation
1,6111,315667.741,0611,015
Other Operating Activities
10,08012,2543,7531,518-87.96
Change in Accounts Receivable
1,486-3,300-6,92245.46-38.64
Change in Unearned Revenue
-604.9-454.55-499.721,154140.79
Change in Other Net Operating Assets
-6,2611,30864.83450.07-278.35
Operating Cash Flow
13,13617,860-4,874-2,644-3,908
Capital Expenditures
-774.59-353.69-223.73-795.7-451.6
Sale of Property, Plant & Equipment
--23.14-0.63
Cash Acquisitions
-----0.04
Sale (Purchase) of Intangibles
-24.47-8.94-1,456--69.8
Investment in Securities
-121,938-33,390-14,412-13,4725,888
Other Investing Activities
-112.48-182.03-319.85-232.63-276.82
Investing Cash Flow
-122,849-33,935-16,389-14,5005,090
Long-Term Debt Repaid
--538.39-475.11-454.13-257.1
Net Debt Issued (Repaid)
-606.12-538.39-475.11-454.13-257.1
Issuance of Common Stock
77,35976,066-5,220161.66
Other Financing Activities
0--76.871.83
Financing Cash Flow
119,687118,46224,27015,734-23.61
Foreign Exchange Rate Adjustments
-50.97-467.718.760.615.23
Miscellaneous Cash Flow Adjustments
-0-0-0-
Net Cash Flow
9,923101,9203,026-1,4101,163
Free Cash Flow
12,36117,506-5,098-3,440-4,360
Free Cash Flow Margin
22.81%37.03%-43.35%-2009.11%-3924.65%
Free Cash Flow Per Share
216.93352.83-143.49-100.72-130.42
Cash Interest Paid
92.7151.7187.55118.44122.89
Cash Income Tax Paid
3,3583,295130.5-5.4713.28
Levered Free Cash Flow
-10,316-2,704-520.51-
Unlevered Free Cash Flow
-10,351-2,646-446.09-
Change in Working Capital
-5,379-2,447-7,3571,650-176.2